This inventor holds 1 USPTO granted patent. Top assignees: Albert Einstein College of Medicine, University of Pittsburgh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 514 
1 out of 1,963 
Years Active: 2025
Title: Kristie E Darrah: Innovator in Sulfotransferase Inhibition
Introduction
Kristie E Darrah is a notable inventor based in Pittsburgh, PA (US). She has made significant contributions to the field of biochemistry, particularly in the area of sulfotransferase inhibition. Her work has implications for various therapeutic applications.
Latest Patents
Kristie E Darrah holds a patent titled "Small molecule inhibition of sulfotransferase SULT1A3." This patent provides small molecule compounds and methods for inhibiting human sulfotransferase 1A3 (SULT1A3) using these compounds. The patent also discloses methods of manufacturing and treatment, showcasing her innovative approach to addressing biochemical challenges. She has 1 patent to her name.
Career Highlights
Throughout her career, Kristie has worked with prestigious institutions such as the University of Pittsburgh and Albert Einstein College of Medicine. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Ian Cook and Mary Frances Cacace. Their collaborative efforts have further advanced the research and development of sulfotransferase inhibitors.
Conclusion
Kristie E Darrah's work in the field of sulfotransferase inhibition exemplifies her dedication to innovation and research. Her contributions continue to influence the scientific community and pave the way for future advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile